Skip to main content
. 2026 Feb 28;15(5):429. doi: 10.3390/cells15050429
EMA European Medicines Agency
FDA Food and Drug Administration
ATMPs Advanced Therapy Medicinal Products
hPL human platelet lysate
OA osteoarthritis
DMEM Dulbecco’s Modified Eagle’s Medium
HE Hematoxylin–Eosin
GMP Good Manufacturing Practice
MHC Major Histocompatibility Complex
MSC Mesenchymal Stem Cells
GLP Good Laboratory Practice
DNA Deoxyribonucleic Acid